Radioactive tracer hunts tumors in early cancer trial
NCT ID NCT07439120
Summary
This early study is testing a new radioactive compound for both imaging and treating advanced solid tumors that have spread. First, 10 patients will get a scan to see if the compound attaches to their tumors. Then, 5 of those patients will receive a low dose of a therapy version of the compound. The main goals are to check safety, see how the body processes the drug, and measure radiation exposure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROTHELIAL CARCINOMA (UC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.